Female infertility associated with anovulation. Female infertility, unspecified
Conditions
Interventions
Intervention 1: TheFirst Interven group (n=70) , received oral contraceptive, GnRH, rFSH and rLH ,150-300 unit subcutaneously. Intervention 2: The second Intervention group (n=70) received oral co
Treatment - Drugs
TheFirst Interven group (n=70) , received oral contraceptive, GnRH, rFSH and rLH ,150-300 unit subcutaneously.
The second Intervention group (n=70) received oral contraceptive, GnRH, rFSH 150-300 Unit subcutaneosly and 75 Unit of HMG
Sponsors
Vice Chancellor or Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 38 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: aged 20-35 years;Tubal or unexplained infertility, regular menstruation cycle between 21 and 35 days; Normal function of uterus according to hysterosalpingography; hysteroscopy or transvaginal ultrasonography; Normal ovaries according to transvaginal ultrasonography during past 6 months prior to study and compatible with normal adnexa and normal ovarian anatomy; Serum FSH level less than 8 IU/l. Exclusion Criteria: Patients with other ovulation disorders such as hypo and hyper-gonadotropic; hypo gonadism; hyper-prolactinemia; thyroid disorders; ovarian or adrenal neoplasms; Cushing syndrome; previous history of systemic diseases such as endocrine and metabolic disorders and a previous history of inappropriate ovarian response to stimulation with gonadotropins (poor responders), prior history of more than 3 unsuccessful IVF; any malformation of sexual organs were excluded
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chemical pregnancy. Timepoint: two weeks after embryo transfers. Method of measurement: Blood test.;Clinical Pregnancy. Timepoint: three weeks after seeing sac fetus. Method of measurement: transvaginal sonography.;Live birth. Timepoint: after delivery. Method of measurement: Live birth.;Abortion. Timepoint: two weeks after embryo transfers. Method of measurement: transvaginal sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of oocyte. Timepoint: six day after treatment. Method of measurement: Transvaginal sonography.;Number of embryo. Timepoint: one day after oocyte pick up. Method of measurement: See under a microscope by a specialist in embryology. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMina Farshbaf Taghinejad
School of Medicine, Tehran University of Medical Sciences.
Outcome results
None listed